Compounds > mifepristone
Page last updated: 2024-08-23

mifepristone and Cardiovascular Diseases

mifepristone has been researched along with Cardiovascular Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davey, A1

Other Studies

2 other study(ies) available for mifepristone and Cardiovascular Diseases

ArticleYear
FDA puts restrictions on use of controversial diabetes drug.
    Mayo Clinic women's healthsource, 2011, Volume: 15, Issue:2

    Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug and Narcotic Control; Drug Approval; Drug Industry; Drug Prescriptions; Humans; Hypoglycemic Agents; Mifepristone; Rosiglitazone; Thiazolidinediones; United States; United States Food and Drug Administration

2011
Mifepristone and prostaglandin for termination of pregnancy: contraindications for use, reasons and rationale.
    Contraception, 2006, Volume: 74, Issue:1

    Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Cardiovascular Diseases; Contraindications; Female; History, 20th Century; Humans; Legislation, Drug; Mifepristone; Pregnancy; Prostaglandins; Risk Factors

2006